Keeping healthcare patients safe while tracking adverse drug event (ADEs) has become an increasingly bigger challenge. In the last few years, the number of safety cases are increasing by up to 15% every year because of the volume of new drugs and growing patient health complexity. This highlights the need for effective monitoring and management systems to keep patients safe with clear sight on rising cost per case.
Our solution streamlines the adverse drug detection process from gathering to analysis and reporting, resulting in enhanced operational efficiency and regulatory compliance. By using AI and machine learning, our solution streamlines data entry, case classification, and analysis, allowing healthcare and life sciences organizations to focus on proactive risk management rather than remedial actions.
Our Pharmacovigilance Case Intake Framework can be implemented in as little as 45 days and cuts costs by up to 60% compared to developing solutions internally.
WinWire’s Pharmacovigilance Case Intake Offering cuts down the expense of the pharmacovigilance process by between 40-60% and shortens the time required for case intake and triage by 40-50%. In addition, our solution addresses the following:
Let’s discuss how we can help you create digital experiences
